Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [634.86 KB]

Communities and civil society living with and/or affected by, and vulnerable to HIV, tuberculosis and malaria from Asia-Pacific and globally signed onto a letter that expressed appreciation to the United States (U.S.) for their recent emergency investment of $3.5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) to fight COVID-19 and at the same time, protect progress against the three diseases and to support sexual and reproductive health programmes. Should this emergency investment not been committed, the COVID-19 Response Mechanism (C19RM) would have ran out of funding.

As of the 12th March 2021, the Global Fund has approved $759 million for C19RM and $229 million through Grant Flexibilities to support countries in their fight against the COVID-19 pandemic and to protect the gains in HIV, TB and malaria. The contribution of the U.S. will support an expansion of COVID-19 testing capacities in low- and middle-income countries, and the provision of personal protective equipment (PPE) to health care workers. This additional contribution will provide further support to ensure that those infected have access to care and treatment (including adequate oxygen supplies). 

As communities and civil society living with and/or affected by, and vulnerable to HIV, TB and malaria in Asia-Pacific and globally, we call upon the global donor community – including the private sector and private foundations to pledge to the Global Fund’s efforts to fight COVID-19 and protect the progress against the three diseases!

Because when the fight is hardest, #HeroesGiveMore!